1963. PrEP Significantly Reduces the Rate of New HIV Diagnoses in US Metropolitan Statistical Areas Independent of Treatment as Prevention (2012–2017)

por Mera-Giler, Robertino M, Das, Moupali, Hawkins, Trevor, Magnuson, David, Asubonteng, Julius, McCallister, Scott
Publicado 2019

Estimation of new HIV diagnosis rates among high‐risk, PrEP‐eligible individuals using HIV surveillance data at the Metropolitan Statistical Area level in the United States

por Mera, Robertino, Scheer, Susan, Carter, Christoph, Das, Moupali, Asubonteng, Julius, McCallister, Scott, Baeten, Jared
Publicado 2019

Plasma concentration of neurofilament light chain protein decreases after switching from tenofovir disoproxil fumarate to tenofovir alafenamide fumarate

por Hermansson, Linn, Yilmaz, Aylin, Price, Richard W., Nilsson, Staffan, McCallister, Scott, Makadzange, Tariro, Das, Moupali, Zetterberg, Henrik, Blennow, Kaj, Gisslen, Magnus
Publicado 2019

Atherosclerotic Cardiovascular Disease Risk Profile of Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate

por Huhn, Gregory D, Shamblaw, David J, Baril, Jean-Guy, Hsue, Priscilla Y, Mills, Brittany L, Nguyen-Cleary, Thai, McCallister, Scott, Das, Moupali
Publicado 2019

Brief Report: Efficacy and Safety of Switching to a Single-Tablet Regimen of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1/Hepatitis B–Coinfected Adults

por Gallant, Joel, Brunetta, Jason, Crofoot, Gordon, Benson, Paul, Mills, Anthony, Brinson, Cynthia, Oka, Shinichi, Cheng, Andrew, Garner, Will, Fordyce, Marshall, Das, Moupali, McCallister, Scott
Publicado 2016

Demographic diversity of US-based participants in GSK-sponsored interventional clinical trials

por Reid, Michel M, Davis, Scott P, Henry, Ouzama N, Mathew, Ashwin A, McCallister, Scott, Nero, Taj T, Rabheru, Sanjit A, Sampson, Shani H, Vanderslice, Tracy F, Williams, Danaé T
Publicado 2023

A Randomized, Open-Label Trial to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Darunavir in Treatment-Experienced HIV-1-Infected Adults

por Huhn, Gregory D., Tebas, Pablo, Gallant, Joel, Wilkin, Timothy, Cheng, Andrew, Yan, Mingjin, Zhong, Lijie, Callebaut, Christian, Custodio, Joseph M., Fordyce, Marshall W., Das, Moupali, McCallister, Scott
Publicado 2017

Safety and Pharmacokinetics of a Tenofovir Alafenamide Fumarate-Emtricitabine based Oral Antiretroviral Regimen for Prevention of HIV Acquisition in Women: A Randomized Controlled...

por Thurman, Andrea R., Schwartz, Jill L., Cottrell, Mackenzie L., Brache, Vivian, Chen, Beatrice A., Cochón, Leila, Ju, Susan, McGowan, Ian, Rooney, James F., McCallister, Scott, Doncel, Gustavo F.
Publicado 2021

1962. Renal Outcomes for Participants Taking F/TAF vs. F/TDF for HIV PrEP in the DISCOVER Trial

por Mills, Anthony, Workowski, Kimberly, Campbell, Thomas, Benson, Paul, Crofoot, Gordon, Salazar, Laura, Ogbuagu, Onyema, Shalit, Peter, Trottier, Benoit, Carter, Christoph C, Wong, Pamela, Brainard, Diana M, McCallister, Scott, Das, Moupali, Doblecki-Lewis, Susanne
Publicado 2019

1288. Bone Safety Outcomes with F/TAF vs. F/TDF for PrEP in the DISCOVER Trial

por Wohl, David, Ruane, Peter, Hosek, Sybil, Creticos, Catherine, Morris, Sheldon, Phoenix, John, Ramgopal, Moti, Brinson, Cynthia, Tremblay, Cecile, Carter, Christoph C, Wong, Pamela, Brainard, Diana M, McCallister, Scott, Das, Moupali, Thompson, Melanie A
Publicado 2019

Equivalent Decline in Inflammation Markers with Tenofovir Disoproxil Fumarate vs. Tenofovir Alafenamide

por Funderburg, Nicholas T., McComsey, Grace A., Kulkarni, Manjusha, Bannerman, Tammy, Mantini, Jessica, Thornton, Bernadette, Liu, Hui C., Zhang, Yafeng, Song, Qinghua, Fang, Liang, Dinoso, Jason, Cheng, Andrew, McCallister, Scott, Fordyce, Marshall W., Das, Moupali
Publicado 2016

Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Patients With Renal Impairment: 48-Week Results From a Single-Arm...

por Pozniak, Anton, Arribas, Jose R., Gathe, Joseph, Gupta, Samir K., Post, Frank A., Bloch, Mark, Avihingsanon, Anchalee, Crofoot, Gordon, Benson, Paul, Lichtenstein, Kenneth, Ramgopal, Moti, Chetchotisakd, Ploenchan, Custodio, Joseph M., Abram, Michael E., Wei, Xuelian, Cheng, Andrew, McCallister, Scott, SenGupta, Devi, Fordyce, Marshall W.
Publicado 2016

Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-bl...

por Mayer, Kenneth H, Molina, Jean-Michel, Thompson, Melanie A, Anderson, Peter L, Mounzer, Karam C, De Wet, Joss J, DeJesus, Edwin, Jessen, Heiko, Grant, Robert M, Ruane, Peter J, Wong, Pamela, Ebrahimi, Ramin, Zhong, Lijie, Mathias, Anita, Callebaut, Christian, Collins, Sean E, Das, Moupali, McCallister, Scott, Brainard, Diana M, Brinson, Cynthia, Clarke, Amanda, Coll, Pep, Post, Frank A, Hare, C Bradley
Publicado 2020